Administration Intravaginal
Conditions
Interventions
Test Product Application
The products will be applied as it is on semi-occlusive dressings, with the aid of
1 mL disposable syringe. Distilled water will be used as a control. The dressings will be pl
Other
Sponsors
Makelab Consultoria Eireli
Labterapi Laboratório de produtos naturais EIRELI EPP
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Women; Age: 18 to 65 years; Phototype: I to IV; Whole skin of the region; Occasional user of products of the category
Exclusion criteria
Exclusion criteria: Participants who refuse to participate in the study in question; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions; Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; History of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Volunteers with a history of allergy to the material used in the study; Background of atopy; Use of vaginal cream; Participants with a history of allergy to products in the tested category; Recent gynecological surgeries; Discharges; History of pathologies aggravated or triggered by ultraviolet radiation; Immunodeficiency sufferers; Kidney, heart or liver transplantation; Forecast of intense sun exposure or tanning session during the period conducting the study; Forecast of bathing in the sea, pool or sauna during the study; Participants who practice water sports; Use of the following medications for systemic topical use: immunosuppressants, antihistamines, non-hormonal anti-inflammatory drugs, and corticosteroids up to two weeks before selection; Treatment with acidic vitamin A and / or its derivatives orally or topically up to 01 month before the beginning of the study; Vaccination forecast during the study or up to 03 weeks before the study; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is hoped to prove the absence of primary skin irritation reactions and accumulated and allergic reactions by sensitization by investigative products. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is hoped to guarantee the safety of the products to the community. | — |
Countries
Brazil
Contacts
Public ContactCassiano Escudeiro
Ipclin - Pesquisa Clínica Integrada
Outcome results
None listed